Lung cancer, primarily caused by smoking, was an epidemic of the 20th century, with is peak being recorded in the 1990s. Thus, lung cancer was the number 1 deadly cancer, especially in the male population with over 200 deaths per 100,000 people. In recent years, mortality from lung cancer has decreased significantly, approximately by 25% in total, with an annual drop that reaches 4 to 5%, thanks to the reduction of smoking, the improvement of diagnostic methods, the early diagnosis of the disease, but also to the improvement of therapeutic protocols. New treatment regimens have increased the average rate of survival of patients. A share in the successful treatment of the disease also belongs to radiotherapy, as technological advances and the development of newer techniques contributed to the more accurate targeting of the tumor region. Lung cancer is asymptomatic in the initial stages. For this reason, screening with an annual low dose chest CT scanning is essential in smokers. We also assess the “smoker’s cough” – especially when it changes or worsens – or persistent chest pain. Lung cancer is not a single disease, but a group of different diseases that require a different approach and treatment. It is treated according to the histological type and the stage of the disease. With radiotherapy we treat lung cancer bloodlessly, painlessly and in a short time period, is small and large tumors, even in tumors difficult to access with the surgical scalpel.
Initially, the dimensions of the tumor are stabilized, which gradually shrinks until it disappears, with the least possible side effects.
The anatomical particularities of the lung, led us to develop special radiotherapy techniques.
We target the tumor with great precision and in less time, and at the same time we protect healthy tissues to a significant degree.
With advanced systems and techniques, we immobilize the patient and synchronize their breathing, eliminating the risk of a wrong movement, while with sophisticated systems we verify the accuracy of targeting.
Stereotactic radiotherapy treats locally detected lung cancer, with high targeting and precision.
In early stages, stereotactic radiotherapy is carried out with multiple high radiation dose beams, however over a small area. We irradiate with a high dose in a short period of time, of about three, five to seven days, instead of the 35 days that classical radiotherapy requires. The results are equivalent, with low and controllable side effects.
In locally advanced stages, classical radiotherapy with its modern techniques, in combination with chemotherapy, can provide a bloodless solution.
Radiotherapy can play a role after the surgical removal of the tumor, where we apply classical radiotherapy as well as in case of recurrence or metastasis of the cancer.
Thanks to its immunostimulatory action, the interest in radiotherapy expanded with the introduction of immunotherapy into the range of methods for the treatment of cancer. The two treatments work together and improve lung cancer survival rates. Positron Emission Computed Tomography (PET/CT) combines two methods, positron emission tomography (ΡΕΤ) and computed tomography (CT) and provides at the same time anatomical and metabolic information, imaging the entire human body, with the administration of a radiopharmaceutical. During the examination, the image of cancer cells is “brighter” and thus they are easier to detect. PET scan is useful for the accurate determination of the stage of the disease and in the planning of radiotherapy.
We have modern equipment, know-how and we provide safe treatments with low side effects. I am fortunate to operate state-of-the-art equipment, that offers my patients the best results with the lowest possible side effects. Cancer is no longer an incurable disease. Since the 1970s, the patients who recovered from cancer have multiplied globally. Radiotherapy is the most personalized treatment because it is designed and carried out according to the needs of each patient. We are here to offer treatment and care, individually for each patient.